LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
16,883,918
Share change
+389,671
Total reported value
$53,857,003
Price per share
$3.19
Number of holders
37
Value change
+$1,089,648
Number of buys
9
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q2 2022

As of 30 Jun 2022, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,883,918 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, HealthInvest Partners AB, VANGUARD GROUP INC, D. E. Shaw & Co., Inc., ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., TANG KEVIN C, GEODE CAPITAL MANAGEMENT, LLC, and Bank of New York Mellon Corp. This page lists 37 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.